0.3402  0.008 (2.35%)		08-25 16:00
Open: 0.34 High: 0.3402 Volume: 557,731		Pre. Close: 0.3324 Low: 0.3303 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	0.76	1-year :	1.05
Resists	First :	0.65	Second :	0.89
Pivot price	0.38
Supports	First :	0.25	Second :	0.2
MAs	MA(5) :	0.34	MA(20) :	0.41
	MA(100) :	0.53	MA(250) :	2.82
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	8.4	D(3) :	7.7
RSI	RSI(14): 45
52-week	High :	14.14	Low :	0.25

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ GCTK ] has closed above bottom band by 31.1%. Bollinger Bands are 42.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.34 - 0.34	0.34 - 0.34
Low:	0.33 - 0.33	0.33 - 0.33
Close:	0.34 - 0.34	0.34 - 0.34

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

Tue, 25 Aug 2026
Lōkahi plans one shot per visit instead of 15 for honeybee-venom treatment - Stock Titan

Wed, 19 Aug 2026
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan

Mon, 17 Aug 2026
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire

Thu, 30 Jul 2026
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - Benzinga

Thu, 30 Jul 2026
GlucoTrack surges as traders revisit Lōkahi merger and new financing package | GCTK Stock News - Quiver Quantitative

Wed, 29 Jul 2026
Glucotrack (NASDAQ: GCTK) revises $900,000 debt-for-stock deal - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	11 (M)
Shares Float	11 (M)
Held by Insiders	11.5 (%)
Held by Institutions	6.6 (%)
Shares Short	2,560 (K)
Shares Short P.Month	510 (K)

EPS	1.14
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.35
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-164.5 %
Return on Equity (ttm)	-620.7 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.45
Qtrly Earnings Growth	0 %
Operating Cash Flow	-16 (M)
Levered Free Cash Flow	-10 (M)

PE Ratio	0.29
PEG Ratio	0
Price to Book value	-1.01
Price to Sales	0
Price to Cash Flow	-0.23

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.